A Lancet Psychiatry cohort found the link held against other diabetes drugs too. Randomized trials so far show weight and HbA1c gains but no clear change in psychiatric symptoms.
Recap by typeshit. Full story at The Clinical Trial Vanguard.
The once-daily pill blocks the IL-23 receptor and helped people with moderate to severe ulcerative colitis respond more often than placebo, a new study reports.
Bikman welcomes a new result but argues the likely cause is tirzepatide bringing insulin down rather than the drug slowing aging itself. His view, not a study claim.
Marchione makes the case for pairing GLP-1s with drugs that target amylin, the hormone released after meals that signals fullness to the brain.
Regen says the placebo group saw a 9% drop, while people on retatrutide also lost 31 lb on average and saw systolic blood pressure fall 14 points.
Avi Roy points out that the largest test so far found no memory benefit from the drug in Ozempic, despite hopes raised by health record studies.
Analysts say US prescriptions for both Novo's and Lilly's oral weight loss pills fell during the holiday-shortened week, suggesting a calendar effect rather than a demand drop.
Loading…